
GC33022
Naquotinib
Also listed as Naquotinib (ASP8273)
Naquotinib (ASP8273) (ASP8273) is an orally available, mutant-selective and irreversible EGFR inhibitor; with IC50s of 8-33 nM toward EGFR mutants and 230 nM for EGFR
ChemicalCAS1448232-80-1MW562.71FormulaC30H42N8O3
- CAS number
- 1448232-80-1
- Molecular weight
- 562.71
- Formula
- C30H42N8O3
- Solubility
- DMF: 30mg/ml,DMSO: 2 mg/ml,Ethanol: 30mg/ml
- InChIKey
- QKDCLUARMDUUKN-XMMPIXPASA-N
- Catalogue number
- GC33022
- Brand
- GLPBIO
Computed properties PubChem CID 71667668 · XLogP 3.4 · TPSA 120 Ų · H-bond donors 2
- XLogP
- 3.4
- TPSA
- 120 Ų
- H-bond donors
- 2
- H-bond acceptors
- 9
- Rotatable bonds
- 9
- Heavy atoms
- 41
SMILES CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)O[C@@H]5CCN(C5)C(=O)C=C
Computed descriptors from PubChem (CID 71667668), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il